James P. Allison, Ph.D., a trailblazer in cancer immunotherapy, has been awarded the Lifetime Achievement Award by the American Association…
A groundbreaking study funded by the National Institutes of Health (NIH) has successfully miniaturized the CRISPR gene-editing system, enabling unprecedented…
Researchers funded by the National Institutes of Health (NIH) have made a significant breakthrough in CRISPR gene-editing technology by developing…
China has announced a breakthrough in its nuclear power technology with the engineering application of its first 0.45-meter aramid filter…
China has achieved a technological milestone in nuclear power with the engineering application of its first 0.45-meter aramid filter element,…
P2 Science, a Connecticut-based biotechnology firm, has gained international recognition for its groundbreaking innovation in fragrance technology, Citropol F. The…
P2 Science, a leading innovator in green chemistry, has garnered global attention for its groundbreaking development of Citropol F, a…
The U.S. Food and Drug Administration (FDA) has rejected Replimune Group Inc.’s experimental melanoma therapy, sending the company’s shares into…
Kymera Therapeutics has secured Fast Track designation from the U.S. Food and Drug Administration (FDA) for KT-621, its investigational oral…
Kymera Therapeutics announced today that its experimental drug KT-621 has received Fast Track designation from the U.S. Food and Drug…